Primary percutaneous coronary intervention for coronary thrombosis during cisplatin, etoposide and bleomycin combination therapy under thromboprophylaxis with nadroparin
International Journal of the Cardiovascular Academy · 2015
DOI: 10.1016/j.ijcac.2015.07.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of the Cardiovascular Academy, 2015. Verfasst von Mehmet Yaman und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Testicular cancer is the most common solid tumor among young men. Regimens containing cisplatin and bleomycin in combination with etoposide are used for treatment of non-seminomatous germ cell testicular tumors. Cancer patients are at increased risk of thrombosis. Epidemiological studies have identified chemotherapy as an additional risk factor for a hypercoagulability state and thrombosis. The risk is more pronounced with cisplatin-containing chemotherapy. Thromboprophylaxis with LMWH during chemotherapy has demonstrated to give substantial risk reduction of thromboembolic events. We present a case of acute myocardial infraction during combined chemotherapy with bleomycin, etoposide and cisplatin for testicular cancer under thromboprophylaxis with nadroparin. Emergency coronary angiography revealed total occlusion of the right coronary artery by a thrombus which was successfully removed by aspiration.
Zitieren
APA
Yaman, M., Ebinc, S., Beton, O., & Mete, T. (2015). Primary percutaneous coronary intervention for coronary thrombosis during cisplatin, etoposide and bleomycin combination therapy under thromboprophylaxis with nadroparin. International Journal of the Cardiovascular Academy. https://doi.org/10.1016/j.ijcac.2015.07.009
Vancouver
Yaman M, Ebinc S, Beton O, Mete T. Primary percutaneous coronary intervention for coronary thrombosis during cisplatin, etoposide and bleomycin combination therapy under thromboprophylaxis with nadroparin. International Journal of the Cardiovascular Academy. 2015. doi:10.1016/j.ijcac.2015.07.009
BibTeX
@article{Yaman2015,
author = {Yaman, Mehmet and Ebinc, Senar and Beton, Osman and Mete, Turkan},
title = {Primary percutaneous coronary intervention for coronary thrombosis during cisplatin, etoposide and bleomycin combination therapy under thromboprophylaxis with nadroparin},
journal = {International Journal of the Cardiovascular Academy},
year = {2015},
doi = {10.1016/j.ijcac.2015.07.009}
}
EUVIMED